2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Craniofacial Abnormalities in 2 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Craniofacial Abnormalities: Congenital structural deformities, malformations, or other abnormalities of the cranium and facial bones.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rosenberger, G | 1 |
Meien, S | 1 |
Kutsche, K | 1 |
Bögel, G | 1 |
Gujdár, A | 1 |
Geiszt, M | 1 |
Lányi, Á | 1 |
Fekete, A | 1 |
Sipeki, S | 1 |
Downward, J | 1 |
Buday, L | 1 |
2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Craniofacial Abnormalities
Article | Year |
---|---|
Oncogenic HRAS mutations cause prolonged PI3K signaling in response to epidermal growth factor in fibroblasts of patients with Costello syndrome.
Topics: Abnormalities, Multiple; Cells, Cultured; Chromones; Craniofacial Abnormalities; Enzyme Inhibitors; | 2009 |
Frank-ter Haar syndrome protein Tks4 regulates epidermal growth factor-dependent cell migration.
Topics: Adaptor Proteins, Signal Transducing; Animals; Cell Movement; Chlorocebus aethiops; Chromones; COS C | 2012 |